1IA
BLFS icon

1620 Investment Advisors’s BioLife Solutions BLFS Stock Holding History

1620 Investment Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.9K Sell
1,979
-295
-13% -$6.89K 0.03% 316
2026
Q1 		$43.4K Hold
2,274
– – 0.03% 320
2025
Q4 		$55K Buy
2,274
+8
+0.4% +$209 0.04% 293
2025
Q3 		$57.8K Sell
2,266
-25
-1% -$593 0.04% 281
2025
Q2 		$49.3K Sell
2,291
-4
-0.2% -$90 0.04% 303
2025
Q1 		$52.4K Hold
2,295
– – 0.04% 290
2024
Q4 		$59.6K Buy
2,295
+675
+42% +$16.8K 0.05% 282
2024
Q3 		$40.6K Hold
1,620
– – 0.03% 327
2024
Q2 		$34.7K Buy
+1,620
New +$31.4K 0.03% 334

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

1620 Investment Advisors's BLFS Position: Q2 2026 in Review

1620 Investment Advisors reduced its BioLife Solutions (BLFS) stake by 13% in Q2 2026, selling an estimated $6.89K and leaving 1,979 shares worth $55.9K. The position accounts for 0.03% of the portfolio, ranked #316.

1620 Investment Advisors first reported a position in BLFS in Q2 2024 and has held it in 9 quarters since. The position peaked at $59.6K in Q4 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • 1620 Investment Advisors held 1,979 shares of BioLife Solutions worth $55.9K as of Q2 2026.
  • 1620 Investment Advisors sold 295 BioLife Solutions shares in Q2 2026, an estimated $6.89K.
  • BioLife Solutions made up 0.03% of 1620 Investment Advisors's portfolio in Q2 2026, its #316 holding.
  • 1620 Investment Advisors first reported a position in BioLife Solutions in Q2 2024 and has held it in 9 quarters since.
  • 1620 Investment Advisors's BioLife Solutions position peaked at $59.6K in Q4 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.